10th IAS Conference on HIV Science | 21-24 July 2019 | Mexico City, Mexico


Programme highlights: HIV prevention advances

posted on

07 May 2019 (Geneva, Switzerland) – The 10th IAS Conference on HIV Science (IAS 2019) will highlight an array of advances in HIV prevention, ranging from new data on promising prevention options to lessons learned from large interventions around the world.

Below are some of the prevention-focused sessions you can expect this July.

Scientific highlights

The following are some of the prevention-related abstracts in the programme.

  • Insights from a “mystery shopper” study in Kenya assessing the experiences of young adults seeking to buy HIV self-test kits
  • Final results from an open-label extension trial of the dapivirine vaginal ring, a new prevention option for women
  • New data on pre-exposure prophylaxis (PrEP) uptake, and research on how to accelerate access
  • Latest insights from studies involving PrEP “on demand”
  • Advances in research on PrEP implants, a potential option to improve PrEP uptake and adherence
  • Progress in HIV vaccine research, including new long-term findings from APPROACH, a study evaluating the safety and immunogenicity of multiple vaccine regimens


Asa Radix

Implementation science around transgender issues
by Asa Radix, Callen-Lorde Community Health Center

Adam Burgener

The role of microbiome in HIV transmission and pathogenesis
by Adam Burgener, University of Manitoba

Carlos Fernando Caceres

Key populations in Latin America: Young men who have sex with men
by Carlos Fernando Caceres, Universidad Peruana Cayetano Heredia


  • Upping the ante: Prevention for impact
  • Prevention is more than PrEP
  • Start stop restart: Supporting effective PrEP use
  • It's complicated: PrEP in practice
  • Interrupting transmission using new testing tools
  • HIV vaccines: Light at the end of the tunnel?
  • Do we know if it works? Evidence to shape the future of HIV prevention measurement
  • Hormonal contraception and HIV risk: Understanding the ECHO trials results, and what’s next for women, providers, policies, and programmes
  • Reaching young people where they are: Creating demand and providing PrEP services for young people
  • Prevention solutions for the next generation: Highlighting adolescent research and participant perspectives in the NIH HIV/AIDS Clinical Trials Networks and the Adolescent Trials Network for HIV/AIDS Interventions (ATN)
  • PrEP implementation for MSM and Trans Women in Latin America – early lessons from the ImPrEP initiative: Reaching, engaging and retaining
  • Prevention revolution: Getting back on track & reducing new HIV infections

Media contact
Mandy Sugrue
Communications Director
[email protected]